S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Factor Therapeutics Stock Price, News & Analysis (ASX:FTT)

0.0040
0.00 (0.00 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
A$0.00
Now: A$0.00
A$0.00
50-Day Range N/A
52-Week Range
A$0.00
Now: A$0.00
A$0.08
Volume250,000 shs
Average Volume433,334 shs
Market Capitalization$4.17 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Factor Therapeutics Limited, a clinical stage biotechnology company, develops treatments for wound care and healing. The company was formerly known as Tissue Therapies Limited and changed its name to Factor Therapeutics Limited in May 2016. Factor Therapeutics Limited is headquartered in Brisbane, Australia.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-7-33343900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.38 million
Cash FlowA$0.00 per share
Book ValueA$0.00 per share

Profitability

Miscellaneous

EmployeesN/A
Outstanding Shares1,042,840,000
Market Cap$4.17 million
Next Earnings DateN/A
OptionableNot Optionable

Receive FTT News and Ratings via Email

Sign-up to receive the latest news and ratings for FTT and its competitors with MarketBeat's FREE daily newsletter.


Factor Therapeutics (ASX:FTT) Frequently Asked Questions

What is Factor Therapeutics' stock symbol?

Factor Therapeutics trades on the ASX under the ticker symbol "FTT."

Has Factor Therapeutics been receiving favorable news coverage?

Press coverage about FTT stock has been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Factor Therapeutics earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Factor Therapeutics.

Who are some of Factor Therapeutics' key competitors?

Who are Factor Therapeutics' key executives?

Factor Therapeutics' management team includes the folowing people:
  • Dr. Rosalind Wilson MBBS, MBA, Consultant
  • Ms. Melanie Farris, Company Sec.

What is Factor Therapeutics' stock price today?

One share of FTT stock can currently be purchased for approximately A$0.00.

How big of a company is Factor Therapeutics?

Factor Therapeutics has a market capitalization of $4.17 million and generates $2.38 million in revenue each year. View Additional Information About Factor Therapeutics.

What is Factor Therapeutics' official website?

The official website for Factor Therapeutics is http://factor-therapeutics.com/.

How can I contact Factor Therapeutics?

Factor Therapeutics' mailing address is L 19 179 Turbot St, BRISBANE, QLD 4000, Australia. The biotechnology company can be reached via phone at +61-7-33343900.


MarketBeat Community Rating for Factor Therapeutics (ASX FTT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  146
MarketBeat's community ratings are surveys of what our community members think about Factor Therapeutics and other stocks. Vote "Outperform" if you believe FTT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FTT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Futures Contract

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel